Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Net Income towards Common Stockholders (2023)

Historic Net Income towards Common Stockholders for Sagimet Biosciences (SGMT) over the last 1 years, with Q4 2023 value amounting to -$8.2 million.

  • Sagimet Biosciences' Net Income towards Common Stockholders changed N/A to -$8.2 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$8.2 million, marking a year-over-year change of. This contributed to the annual value of -$27.9 million for FY2023, which is N/A changed from last year.
  • Sagimet Biosciences' Net Income towards Common Stockholders amounted to -$8.2 million in Q4 2023.
  • Sagimet Biosciences' 5-year Net Income towards Common Stockholders high stood at -$6.4 million for Q3 2023, and its period low was -$8.2 million during Q4 2023.